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Abstract
Background: Type 2 diabetes mellitus (T2D), a metabolic disorder characterized by insulin resistance and relative 
insulin deficiency, is a complex disease of major public health importance. Its incidence is rapidly increasing in the 
developed countries. Complex diseases are caused by interactions between multiple genes and environmental factors. 
Most association studies aim to identify individual susceptibility single markers using a simple disease model. Recent 
studies are trying to estimate the effects of multiple genes and multi-locus in genome-wide association. However, 
estimating the effects of association is very difficult. We aim to assess the rules for classifying diseased and normal 
subjects by evaluating potential gene-gene interactions in the same or distinct biological pathways.
Results: We analyzed the importance of gene-gene interactions in T2D susceptibility by investigating 408 single 
nucleotide polymorphisms (SNPs) in 87 genes involved in major T2D-related pathways in 462 T2D patients and 456 
healthy controls from the Korean cohort studies. We evaluated the support vector machine (SVM) method to 
differentiate between cases and controls using SNP information in a 10-fold cross-validation test. We achieved a 65.3% 
prediction rate with a combination of 14 SNPs in 12 genes by using the radial basis function (RBF)-kernel SVM. Similarly, 
we investigated subpopulation data sets of men and women and identified different SNP combinations with the 
prediction rates of 70.9% and 70.6%, respectively. As the high-throughput technology for genome-wide SNPs 
improves, it is likely that a much higher prediction rate with biologically more interesting combination of SNPs can be 
acquired by using this method.
Conclusions: Support Vector Machine based feature selection method in this research found novel association 
between combinations of SNPs and T2D in a Korean population.
Background
It is estimated that by the year 2030, there will be ~366
million people affected by Type 2 diabetes (T2D) world-
wide [1], with many of those affected lying in the middle
to late adult years group [2]. T2D is genetically heteroge-
neous disease by the complex interplay of several envi-
ronmental factors and susceptibility genes [3]. Single-
nucleotide polymorphism (SNP) exhibits an abundant
form of genetic variations. SNPs can be distinguished
from other rare variations by more than 1% frequency in
the human population when a single nucleotide replaces
one of the three nucleotides. The human genome con-
tains about 10~30 million SNPs with an average SNP
every 100~300 bases. More than 5 million human SNPs
have been identified and the information is publicly avail-
able (NCBI dbSNP Build 129). A SNP in a protein coding
sequence (CDS) can induce amino acid changes, resulting
in functional changes in the protein. Some SNPs in a pro-
moter region can effect transcriptional regulation, and a
SNP in an intron region can affect the splicing or expres-
sion of the gene.
In recent years, genome-wide association studies
(GWAS) have identified a large number of robust associa-
tions between genetic variation and complex human dis-
ease, such as Type 2 diabetes and rheumatoid arthritis
[4]. These approaches have identified common genetic
variants that are associated with the risk of more than 40
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diseases and human phenotypes [5]. In the T2D studies,
candidate gene or genome-wide association approaches
have suggested various putative T2D susceptibility SNP
variants in various genes including TCF7L2,  PPARG,
KCNJ11, CDKN2A/B, FTO, CDKAL1 and so on [6-10].
But individual susceptibility of SNP variants may be dis-
appointingly small or nowhere near enough to explain
estimates of heritability [11]. One possible explanation
for these weak relative risks and low attributable risks is
that the risk may vary across different groups of clinically
and biologically distinct T2D; further, analyzing T2D as a
single disease may obscure the association with these risk
factors. Another possible explanation is the effects of
gene-gene (SNP-SNP) interactions. Most complex dis-
eases result from the poorly understood interaction of
genetic-genetic and genetic-environmental factors. The
biological phenomenon associated with T2D that are
modestly affected by a single SNP might be much greatly
affected by a SNP in combination with additional SNPs in
genes derived from the same or distinct biological path-
ways. In other words, it is difficult to identify disease-
linked variants that are too rare to be picked up by associ-
ation methods and yet have risk alleles of sufficient
effects to allow detection with the use of existing statisti-
cal strategies [12]. A marker strongly related to risk does
not guarantee effective discrimination between cases and
controls [13].
A goal of this research is to assess the rules for classify-
ing the case (T2D) and control (non-T2D) groups along
with considering the potential gene-gene (SNP-SNP)
interactions. Since it is considered that the SNPs are less
influential toward the onset or development of T2D than
combinations of SNPs, our interest is specially focused on
the classification of SNPs that can detect the putative
effects of genetic interactions. Small effects that could,
when combined, have a significant impact on someone's
health including onset of T2D, thus to get overall view of
risk, the effects of the individual SNPs have to be com-
bined [11]. There are several researches designed to
examine the effect of combined SNPs to disease risks.
Some methods have used the multifactor dimensionality
reduction (MDR) algorithm, which identifies all the pos-
sible combinations of SNPs from a set of given SNPs, and
the combination of SNPs that optimally predicts the risk
by minimizing the classification error of cases and con-
trols is finally selected [14]. Goodman and colleagues for-
mulated a polymorphism interaction analysis (PIA)
method, which examines all the possible SNP combina-
tions (similar to MDR) among 94 SNPs in 63 genes stud-
ied in 216 male colon cancer cases and 255 male controls.
They employed two separate functions that cross-validate
and minimize the false-positive results in the evaluation
of SNP combinations to predict the risk of colon cancer
[15].
In the present research, we analyzed the associations
between the combination of SNPs and T2D using a Sup-
port Vector Machine (SVM) - a machine learning algo-
rithm. Classification based on the SVM has several
applications in bioinformatics and computational biology
[16-20]. It has been widely used to predict protein sec-
ondary structures [21], solvent accessibility [22,23], pro-
tein-protein binding sites [24], remote protein homology
detection [25], detection of non-coding RNA [26], pro-
tein domains [27], protein subcellular localization [28-
30], discrimination of outer membrane protein [31], and
gene and tissue classification from the microarray expres-
sion data [32].
Several researchers have recently applied this powerful
machine-learning algorithm--SVM--to the problem of
identifying combinations of SNPs that can predict the
susceptibility toward diseases. Listgarten and colleagues
[33] considered the SNPs from 45 genes of potential rele-
vance to breast cancer etiology in 174 patients as com-
pared to the matched normal controls. They obtained an
accuracy of 69% when using SVMs as the learning algo-
rithm. They concluded that multiple SNPs from different
genes over distant parts of the genome are better at iden-
tifying breast cancer patients than any single SNP alone.
Waddell et al. (2005) have applied SVMs to predict the
susceptibility to multiple myeloma. Their work provided
71% accuracy on a dataset containing 40 cases and 40
controls. Very recently, Uhmn et al. (2009) applied sev-
eral machine learning techniques including SVM to pre-
dict patients' susceptibility to chronic hepatitis from
SNPs [34].
In this research, we analyzed the importance of gene-
gene interactions on T2D risk by investigating 408 SNPs
from 87 genes involved in major T2D-related pathways in
a sample of 462 T2D cases and 456 healthy population
controls. We applied the SVM to discriminate cases and
controls with SNP combination information by means of
a 10-fold cross-validation test. From the target popula-
tion, we achieved 65.3% prediction rate with a combina-
tion of 14 SNPs from 12 genes using the RBF (Radial Basis
Function) kernel SVM. We also investigated men and
women sub-population datasets using the same method,
and identified some different combinations of SNPs with
prediction rates of 70.9% and 70.6%, respectively. For
more precise identification of gene-gene interaction
information in a biological manner, we may need more
precise well-characterized sub-population datasets. In
order to refine the genetic-environment relationship,
more information is required in an epidemiological inves-
tigation. Besides existing statistical methods, we demon-
strated the feasibility of incorporating SVM - a machine
learning algorithm into case-control study.Ban et al. BMC Genetics 2010, 11:26
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Results
Case-Control Association Study
For each SNP, the p-value was calculated based on a chi-
squared test. Based on the test results of 408 SNPs, 27
SNPs showed a significant genotype- or allele-based p-
value (< 0.05) (Table 1). The -log10 p-value from associa-
tion result of SNPs was plotted in each chromosome and
the significant SNPs are circle shape (Figure 1).
This candidate-gene based analysis may have some lim-
itations to detect association from the small population
size (462 cases and 456 controls) and the limited number
of candidate genes (87 putative T2D-related genes). The
result of this classical case-control association study may
need a further replication study with a large independent
target population of cases and controls for establishing
the credibility of a genotype-phenotype association. We
used this classical association study result in the process
of sub-dataset filtering based on the genotype-based p-
value range (Table 2).
Combination of SNPs
We performed SVM training and test analysis to find the
best combination of SNPs. The prediction rates were
determined by the SVM classifier that discriminated the
case-control SNP genotype vectors. At first, we acquired
63.6% of the overall accuracy with the entire 408 SNP
dataset, but we found that the p-value-based filtering
method is useful for obtaining a better prediction rate.
The prediction rate of a higher p-value SNP dataset
(Table 1) did not show the best result (57.6%). This effect
might be attributed to the different effects between a sin-
gle SNP and within a combination of SNPs. This p-value-
based filtering can reduce the search space for gene-gene
interactions from a very large number of all possible com-
binations of SNPs to a manageable dataset.
Another reason is the limitation of the forward selec-
tion method to find the best combination of SNPs. The
entire set of 408 SNPs may contain noise SNPs for for-
ward selection, and some useful SNPs in the ideal combi-
nation may be removed from the very restricted p-value-
based filtered SNP dataset (e.g., 24 SNPs with p < 0.05).
The best prediction rate of the SVM classifier with a
RBF kernel function was 65.3% with 14 SNPs including a
combination from the 240 SNPs with p < 0.6 (Table 2 and
Table 3). In table 3, rs343 was reported the association
with T2D [35], and two of SNPs (rs2070011 and
rs2243250) were reported with not T2D but myocardial
infarction [36,37]. Furthermore, sub-population datasets
of men and women with the RBF kernel, which were
designed to discriminate case and control, yielded slightly
better prediction rates of 70.9% and 70.6%, respectively,
than that of the total population dataset (Table 4, Table 5
and Table 6). These prediction rates are almost similar
with other previous studies using SVM, for example 69%
of Listgarten and colleagues [33], 67.5% of Uhmn et al.
[34], or 53% of Schwender et al. [38]. But, these previous
works used different disease samples and different cross-
validation test, thus it is difficult to compare these predic-
tion rates directly. Considering other environmental and
genetic factors involved in the development of T2D, the
prediction performance was reasonably acceptable. It
may be presumed that including other important genes
and clinical factors including family medical history, we
would obtain more improved prediction rate in the
future. Different results between the entire target popula-
Figure 1 Chromosome distribution for association of SNPs with Type 2 Diabetes. In this panel, Manhattan plot shows distributed variables that 
were generated by genome-wide significance (p-values). Triangle markers at each locus indicate the significant SNPs based on a chi-squared test (p 
value < 0.05). Boxed SNPs represent Top 3 ranked lists.Ban et al. BMC Genetics 2010, 11:26
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tion and men or women sub-population may arise from
the effect of the dataset's size or the well-characterized
sub-population grouping.
We could not find better prediction results by the above
p-value-based filtering as that in Table 2 with men and
women sub-population datasets. This result with a
slightly improved prediction rate may arise from the
effect of a smaller size of sub-datasets (n = 405 and 513)
or the effect of well-characterized (gender-distinguished)
sub-population datasets.
Protein-Protein Interaction Information
On the basis of the results of the combinations of SNPs,
we attempted to find any biological information; one of
the results is the protein-protein interaction (PPI) net-
work (Figure 2), which was constructed from the results
of the combinations of SNPs. Each set of the SNP geno-
type data was not acquired from the fine mapping associ-
ation study; therefore, direct SNP-SNP interaction or
SNP analysis focused on each promoter SNP, intron SNP,
or exon SNP is difficult. This is the reason why we carried
out the analysis at the protein (gene) level in this research
(not the SNP level).
The genomenetwork platform http://genomenet-
work.nig.ac.jp provides protein-protein interaction net-
work from the Y2H experimental data and the public
databases (BIND, MINT and HPRD). Also, it has interac-
Table 1: Summary of the association study (genotype- or allele-based p < 0.05)
Gene dbSNP 
ID(b129)
Chromoso
me
Location Region* Alleles* χ2p-value
Genotype Allele
SELE rs4786 1 167958756 3'UTR G>A 0.0462 0.1299
IL10 rs1554286 1 205010856 intron T>C 0.0470 0.0170
CAP1 rs16837478 1 40207033 3'UTR C>A 0.0489 0.5850
VAMP3 rs707457 1 7753651 nearGene-5 G>T 0.0755 0.0299
VAMP3 novel 1 7775035 3'UTR A>G 0.0567 0.0220
SLC11A1 novel 2 219084963 exon G>A 0.0113 0.0229
RHOQ rs17038378 2 46661749 nearGene-3 W>D 0.0426 0.1773
FGA rs2070022 4 155724398 3'UTR C>T 0.0099 0.0083
FGA rs6050 4 155727040 exon A>G 0.0261 0.0077
FGA rs2070011 4 155731347 nearGene-3 A>G 0.0208 0.0053
IL4 rs2243250 5 132037053 nearGene-5 T>C 0.0090 0.0025
SOD2 rs5746136 6 160023074 intron G>A 0.0948 0.0348
CD36 rs3211908 7 80131852 intron C>T 0.0402 0.1445
LPL rs343 8 19855067 intron C>A 0.0215 0.0075
RAPGER1 rs875968 9 133461085 intron G>A 0.0423 0.1247
IL18 rs1946518 11 111540668 nearGene-5 T>G 0.0097 0.1591
CAT rs17886119 11 34417280 intron C>T 0.0138 0.2849
CAT rs1408034 11 34432364 intron C>T 0.0123 0.2745
TCF1 rs1169288 12 119901033 exon T>G 0.0391 0.6975
TCF1 rs2464196 12 119919810 exon T>C 0.0181 0.9747
SNAP23 rs9302112 15 40607743 intron T>C 0.0414 0.0842
ACE rs4362 17 58927493 exon C>T 0.0384 0.0270
NOS2A rs2297518 17 23120724 exon G>A 0.0109 0.5354
STXBP4 rs9902718 17 50416621 intron T>C 0.0478 0.0156
STXBP4 rs10468513 17 50417902 intron C>A 0.0478 0.0156
STXBP4 rs11658717 17 50431985 intron A>G 0.0396 0.0128
ASPSCR1 novel 17 77562902 intron G>T 0.0456 0.0511
* Alleles and region for which the effect is estimated refer to the positive strand based on NCBI build 36Ban et al. BMC Genetics 2010, 11:26
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tion property and gene annotation information. We
obtained gene interaction information from PPI database.
Circles (proteins) are included in the results of the combi-
nation of SNPs, and circles are collected from the entire
PPI information database to connect with the squares.
The construction of an indirect PPI network of two pro-
teins is unnecessary from the biological viewpoint; there-
fore, we permit only two or fewer proteins (squares)
between two proteins (circles) in Figure 2. We could eas-
ily find the same proteins among the target population
datasets and the target-population-specific proteins in
these three PPI networks. PPI network of Figure 2a con-
tains 7 genes from the SNP combination result of 12
genes (14 SNPs) in Table 3. Other PPI network of Figure
2b and 2c contains 4 genes and 6 genes from the SNP
combination results of men and women sub-data sets in
Table 2: Prediction rate of combinations of SNPs with genotype-based p-value filtering
p-value range No. of SNPs [1] Prediction rate No. of SNPs [2]
Overall Sensitivity Specificity
< 0.05 24 0.576 0.545 0.607 4 SNPs
< 0.1 40 0.600 0.593 0.607 6 SNPs
< 0.2 92 0.632 0.660 0.603 10 SNPs
< 0.3 129 0.642 0.630 0.654 12 SNPs
< 0.4 169 0.642 0.630 0.654 12 SNPs
< 0.5 199 0.651 0.571 0.732 13 SNPs
< 0.6 240 0.653 0.567 0.739 14 SNPs
< 0.7 290 0.651 0.610 0.693 12 SNPs
< 0.8 335 0.636 0.721 0.550 7 SNPs
< 0.9 372 0.636 0.721 0.550 7 SNPs
<1.0 408 0.636 0.721 0.550 7 SNPs
[1] No. of SNPs for each genotype-based p-value range; [2] No. of SNPs for each combination
Table 3: List of 14 SNPs for the best combination of SNPs
Gene dbSNP ID Chromosome Location Region Allele
IRS1 rs6436635 2 227373922 nearGene-5 G>A
SLC11A1 Novel* 2 17459455 exon G>A
FGA rs2070011** 4 155731347 5'UTR A>G
SPP1 rs2853749# 4 89116838 intron C>T
IL4 rs2243250 5 132037053 nearGene-5 T>C
IL4 rs56279116 5 132038071 exon G>A
PPARD rs9658173 6 35502649 3'UTR G>A
LPL rs343## 8 19855067 intron C>A
TCF1 rs2464196 12 119919810 exon T>G
ACE rs13306087 17 58910142 exon G>A
ASPSCR1 Novel* 17 77562902 intron G>T
NOS2A rs9282801 17 23120600 intron G>T
INSR rs2303672 19 7119405 intron A>G
INSR rs3745548 19 7103703 intron A>G
* Novel SNP in KHGS does not exist on dbSNP database.
** rs2070011 is associated with myocardial infarction [36]
#rs2243250 is associated with myocardial infarction [37]
##rs343 is associated with T2D [44]Ban et al. BMC Genetics 2010, 11:26
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Table 5 and 6, respectively. IL4 (interleukin 4) gene is the
common gene among these three PPI networks and IL4,
INSR, and IRS1 genes are common between Figure 2a
(total population set) and 2c (women sub-population set).
Discussion
I t  i s  w i d e l y  a g r e e d  t h a t  c o m p l e x  d i s e a s e s  a r e  t y p i c a l l y
caused by the joint effects of multiple genetic variations
instead of a single genetic variation. The gene-gene (epi-
static) interactions of SNPs are believed to be very impor-
tant in determining individual susceptibility to complex
diseases. Thus, it is desirable to develop an effective
method to search gene-gene interactions in human
genome data. Recently, some computational methods
have been proposed to address this issue using Multifac-
tor Dimensional Reduction (MDR), or machine learning
algorithms [39]. To study complex disease such as T2D, it
is possible that many genes contribute to a T2D by their
interaction with other genes, while main effects of the
individual gene may be small or absent. Therefore, we
developed the method that specifically designed to detect
multiple disease SNPs, possibly on different chromo-
somes using SVM. This approach could be useful for
identification of potential disease markers which geno-
type patterns are significantly associated with a high sus-
ceptibility.
This analysis includes the SNPs information of 87 T2D-
related genes from fatty acid binding/translocation,
GLUT4 translocation, and insulin signal pathways. A pri-
mary function of insulin is to stimulate the transport of
glucose into target tissue, prominent among which are
skeletal muscle, cardiac muscle, and adipose tissue. Insu-
lin achieves this effect by inducing the translocation of
GLUT4 glucose transporters from an intracellular vesicu-
lar compartment to the plasma membrane. Under basal
condition, GLUT4 cycles between this intracellular com-
partment and the plasma membrane. SNAP23 is required
for insulin-induced GLUT4 translocation to the plasma
membrane and that it mediates the formation of a com-
plex between syntaxin4 and VAMP2 [40].
T2D results from impairment in both insulin sensitivity
and insulin secretion. Several genes have been implicated
that might contribute significantly to the risk of T2D,
including TCF7L2, PPARG, KCNJ11, CDKN2A/B and so
on [6,8-10]. T2D is one of the typical complex disease
(polygenic disorder), which likely associated with the
effects of multiple genes (SNPs) in combination with life-
style and other environmental factors. In this research,
Table 4: Prediction rates of the SVM classifiers with different target populations
Target population Sensitivity Specificity Overall accuracy No. of SNPs for each 
combination
Total 0.567 0.739 0.653 14 SNPs
Men# 0.714 0.704 0.709 12 SNPs
Women## 0.715 0.696 0.706 19 SNPs
# 199 Cases; 206 Controls
## 263 Cases; 250 Controls
Table 5: List of 12 SNPs for the best combination of SNPs (men)
Gene dbSNP ID Chromosome Location Region Allele
LEPR rs1805134 1 65839697 exon A>G
PRKCZ rs3795277 1 1970978 nearGene-5 A>C
PPARG rs13306747 3 12433274 exon C>G
FABP2 rs1799883 4 120461350 exon G>A
UCP1 novel 4 141848403 promoter G>A
IL4 novel 5 132038071 exon G>A
LPL rs3208305 8 19867928 3'UTR A>T
LPL rs13702 8 19868772 3'UTR A>G
STXBP4 rs1894936 17 50475854 intron A>G
LDLR rs6413504 19 11102915 intron A>G
LDLR rs1433099 19 11103658 3'UTR G>A
ACAS2 novel 20 32926612 promoter G>TBan et al. BMC Genetics 2010, 11:26
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we analyzed the candidate genes data set, thus the result
does not contain these known significant SNP markers,
including TCF7L2, PPARG, KCNJ11 and so on.
The result from Table 1 (all cases, combined versus
controls) indicated weak associations with the risk factors
investigated. This led us to stratify by sub-grouping by
gender to see whether some potential associations may
have been obscured by considering T2D as one disease.
In this research, we first made two subpopulation data
sets by gender (T able 4, and Figure 2). Epidemiological
evidence suggests that sex differences exist in T2D. The
prevalence of T2D is higher in men than women. Glob-
ally, diabetes prevalence is similar in men and women but
it is slightly higher in men < 60 years of age and in women
at older ages [1]. This difference may possibly result from
the differences in insulin sensitivity and regional body fat
deposition [41,42].
Yeh et al. [43] used a conditional knockout strategy to
generate androgen receptor (AR) knockout mice to study
the relationship between androgen-AR and insulin sensi-
tivity, and Lin et al. reported the influences of loss of AR
on insulin and leptin resistance. Loss of AR may contrib-
ute to an increase of leptin levels and leptin resistance,
which may play important roles for the development of
obesity and insulin resistance. Important factors such as
age at onset of T2D can also be incorporated in the mod-
eling to further partition phenotypic variation or for
defining subtypes of the phenotype.
As high-throughput technology for genome-wide SNP
genotyping (500 K or 1 mega) improves and as more
SNPs are identified, it is likely that much higher predic-
tion rate will be achieved and a useful clinical system
developed. For the biologically more precise identifica-
tion of gene-gene interaction's effect for T2D, we may
need more precise well characterized subpopulation data
sets and more powerful computational power and
method and so on. Besides existing statistical methods,
we demonstrated the feasibility of incorporating SVM - a
machine learning algorithm into case-control study. We
plan to develop the method using machine learning algo-
rithm in the future to search gene-gene interactions for
our new Genome-Wide Association Study (GWAS) data
[44].
Conclusions
We have found novel association between combinations
of SNPs and T2D in a Korean population. We proposed
gene-gene interaction considering candidate genes asso-
ciation study using SVM based feature selection method
in this research.
Methods
Data and Data Preprocessing
Our dataset consists of 408 SNP data distributed over
putative 87 T2D-related genes in 462 cases (patients) and
456 normal controls. The T2D cases, confirmed and
Table 6: List of 19 SNPs for the best combination of SNPs (women)
Gene dbSNP ID Chromosome Location Region Allele
CAP1 rs16837478 1 40207033 3'UTR C>A
IL10 rs1554286 1 203332628 intron T>C
LEPR rs13306523 1 65603011 5'UTR C>T
MTHFR rs2274976 1 11785193 exon, nearGene-3 G>A
SELE rs5355 1 166427528 exon C>T
VAMP3 novel 1 7775035 3'UTR A>G
IRS1 rs6436635 2 227373922 nearGene-5 G>A
IRS1 rs1801278 2 227486049 exon G>A
NEUROD1 rs1801262 2 182368961 exon G>A
SLC11A1 novel 2 219084963 exon G>A
GPX1 rs3811699 3 49371364 nearGene-5 A>G
IL4 novel 5 132038071 exon G>A
SLC27A4 rs17848327 9 128192130 intron G>A
MMP2 rs17859889 16 54077202 intron C>T
MMP2 rs17860021 16 54097255 3'UTR G>A
ASPSCR1 novel 17 77528191 nearGene-5 G>C
STXBP4 rs10468513 17 50417902 nearGene-5 C>A
STXBP4 rs11658717 17 50431985 intron A>G
INSR novel 19 7135243 intron G>CBan et al. BMC Genetics 2010, 11:26
http://www.biomedcentral.com/1471-2156/11/26
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diagnosed in the Ansan and Ansung cohort study area,
were identified from the Korean Health and Genome
Study (KHGS). The Ansan area primary represents an
urban community, whereas the Ansung area represents a
rural community in Korea. These two cohort studies
include information on 87 T2D-related genes from fatty
acid binding/translocation, GLUT4 (insulin-responsive
glucose transporter 4) translocation, and insulin signal
pathways. We selected these three pathways with refer-
ence survey [45-48]. Among identified polymorphisms,
408 SNPs were selected based on location (CDS (protein
coding sequence), intron, UTR (Untranslated region),
promoter etc), frequency, linkage disequilibrium (LD)
status and so on. The number of SNPs occurring in the
CDS, intron, UTR, near gene region (promoter) and
intergenic region was 77, 169, 53, 73 and 36, respectively
(additional file 1). In this research, 462 cases were defined
from two cohort studies as T2D subjects according to the
World Health Organization (WHO) criteria. The 456
unrelated normal control people have no history of T2D,
Figure 2 PPI network from the SNP combination of (a) total population set, (b) men sub-population set, and (c) women sub-population set. 
The largest PPI network at each population set was constructed using PPI information database http://genomenetwork.nig.ac.jp. Circles are included 
in the best combination of SNPs from SVM results and square proteins are included to construct circle-circle connected proteins network.Ban et al. BMC Genetics 2010, 11:26
http://www.biomedcentral.com/1471-2156/11/26
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no first-degree relatives with T2D, fasting plasma glucose
level less than 126 mg/dL, plasma glucose level 120 min
after glucose ingestion of less than 140 mg/dL, and
HbA1C level (glycosylated hemoglobin) of less than 5.8%.
Further, the normal control people do not have a history
of diabetes, hypertension, and dyslipidemia. In this study,
all the people of case and control were more than 60 years
of age.
For each SNP, the p-value was calculated based on a
chi-squared test without adjustment for other confound-
ing variables (Table 1). In this paper, we applied SVM to
predict the susceptibility to T2D using SNP genotype
data. From the view point of binary classification, we
treated T2D cases as positive samples and controls as
negative samples, and we used SNP variants as categori-
cal features that have three possible genotype values at a
locus. Usually, a SNP genotype is represented by a num-
ber that matches 1, 2, or 3, where 1 represents the
homozygous site with a major allele, 2 represents a
heterozygous site, and 3 represents a homozygous site
with a minor allele [33]. Waddell et al. (2005) have
applied SVMs to predict the susceptibility to multiple
myeloma using -1, 0, 1, where 0 represents a heterozy-
gous site and -1 and 1 arbitrarily represent homozygous
sites. The preprocessing method used in this research
was the same as that used by Listgarten et al. (2004) [33].
Support Vector Machine
A SVM is a learning algorithm that learns a classifier
from a set of positively and negatively labeled training
vectors, which can be used to classify new unlabelled test
samples. The SVM learns the classifier by mapping the
input training samples into a possibly high-dimensional
feature space, and seeking a hyperplane in this space that
separates the two types of examples with the largest pos-
sible margin, i.e., the distance to the nearest points. If the
training set is not linearly separable, the SVM finds a
hyperplane that optimizes the trade-off between good
classification and large margin with a slack variable and
kernel trick. For an actual implementation, we used the
freely downloadable SVM-light package [49]. We tested
linear, polynomial, and radial basis function (RBF) ker-
nels with various parameters, and the final results were
acquired with the RBF kernel and parameter gamma 1
that yielded the best prediction rate. We treated T2D
cases as positive samples and controls as negative sam-
ples, and used SNP genotypes as categorical features. We
adopted SVM to discriminate T2D cases against controls
in this research.
Feature Selection
For large datasets, an exhaustive consideration of all the
possible SNP combinations can become computationally
infeasible. Therefore, we employed a feature selection
procedure to find the best putative combination of SNPs
according to forward selection for handling datasets with
a genotype of SNPs. In population studies, this kind of
selection of informative SNPs was usually developed for
population identification [50]. In this work, forward
selection was started by first selecting the SNP feature
that yielded the best fit for the independent test set using
SVM training and test at a time. This SNP feature was
used to test all the combinations with the remaining 407
(408 - 1) SNPs in order to find the best pair of SNP fea-
tures. This process continues step by step until increasing
the size of the current subset leads to a lower overall
accuracy. We adopted the 10-fold cross-validated classifi-
cation accuracy for the selection criteria in this work. The
requirement of the best prediction rate at each step yields
the highest overall accuracy with regard to both sensitiv-
ity and specificity (≥ 0.45). The purpose of this require-
ment is to avoid the extremely low sensitivity or
specificity with the highest overall accuracy.
Since we have a relatively small number of people (462
cases and 456 controls) in our dataset, it is expected that
training with the complete set of 408 SNP features may
cause overfitting. Hence, we performed forward selection
with SNP genotype features to find a good smaller feature
set (a combination of SNPs). Note that forward selection
does not necessarily find the best combination of SNPs.
However, it usually results in a combination that comes
close to the optimum solution, and it needs relatively less
computational complexity. If we have a smaller datasets
and a more powerful computer, step-wise feature selec-
tion may be a better method than the forward selection
method in this study.
Cross-Validation Test
The prediction rates of the SVM classifiers were exam-
ined by the 10-fold cross-validation test, where each case
and control dataset is randomly divided into 10 subsets of
approximately the same size. The SVM classifiers were
trained 10 times, leaving out one of the subsets from the
training each time. This single subset was used to esti-
mate the prediction rate of the trained SVM classifier.
The prediction rate of the SVM classifiers was evaluated
using three measures, namely, sensitivity, specificity, and
overall accuracy.
sensitivity
TP
TP FN
specificity
TN
TN FP
overallaccuracy
TP T
=
+
=
+
=
+ N N
TP TN FP FN ++ +Ban et al. BMC Genetics 2010, 11:26
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where TP, FP, TN, and FN refer to the number of true
positives, false positives, true negatives, and false nega-
tives statuses (case or control), respectively. Sensitivity
measures the ability to correctly predict T2D cases, while
specificity measures the ability for correctly reject con-
trols. The kernel functions and parameters for the classi-
fication algorithms were optimized during the 10-fold
cross-validation tests, while avoiding overfitting prob-
lems.
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